Drug Combo Ups Survival in Pancreatic Ca
SAN FRANCISCO (MedPage Today) -- Patients with metastatic pancreatic cancer lived significantly longer when they received a two-drug combination instead of standard monotherapy, results of a large international study showed.
Tags:
Drug Combo Ups Survival in Pancreatic Ca,
Pancreatic Cancer Latest News